From Table 3, we can conclude that the detection of PSA glycoforms shows superior clinical performance and significant advantages over PSA tests, in terms of increased sensitivity and specificity, particularly when PSA concentration is in the diagnostic grey zone, being useful to distinguish between aggressive and indolent prostate cancers and to avoid unnecessary biopsies [180]. Here, KLK3 is linked to prostate cancer.